{"id":"https://openalex.org/W2885057308","doi":"https://doi.org/10.1080/03007995.2018.1507315","title":"Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study","display_name":"Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study","publication_year":2018,"publication_date":"2018-08-01","ids":{"openalex":"https://openalex.org/W2885057308","doi":"https://doi.org/10.1080/03007995.2018.1507315","mag":"2885057308","pmid":"https://pubmed.ncbi.nlm.nih.gov/30067119"},"language":"en","primary_location":{"id":"doi:10.1080/03007995.2018.1507315","doi":"https://doi.org/10.1080/03007995.2018.1507315","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1507315","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101475376","display_name":"Yukihiro Koretsune","orcid":"https://orcid.org/0000-0002-6105-6986","observed_orcids":["https://orcid.org/0000-0002-6105-6986"]},"institutions":[{"id":"https://openalex.org/I4210090372","display_name":"Osaka National Hospital","ror":"https://ror.org/00b6s9f18","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210090372","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukihiro Koretsune","raw_affiliation_strings":["Cardiovascular Division, National Hospital Organization, Osaka National Hospital, Osaka, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Division, National Hospital Organization, Osaka National Hospital, Osaka, Japan;","institution_ids":["https://openalex.org/I4210090372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101424780","display_name":"Koichiro Kumagai","orcid":"https://orcid.org/0000-0002-2507-5565","observed_orcids":["https://orcid.org/0000-0002-2507-5565"]},"institutions":[{"id":"https://openalex.org/I4405256933","display_name":"Fukuoka Sanno Hospital","ror":"https://ror.org/04pj4k457","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405256933"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichiro Kumagai","raw_affiliation_strings":["Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka, Japan;","institution_ids":["https://openalex.org/I4405256933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025141510","display_name":"Shinichiro Uchiyama","orcid":"https://orcid.org/0000-0002-6280-8190","observed_orcids":["https://orcid.org/0000-0002-6280-8190"]},"institutions":[{"id":"https://openalex.org/I4210162813","display_name":"Sanno Medical Center","ror":"https://ror.org/055mpn097","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210162813"]},{"id":"https://openalex.org/I4405256373","display_name":"Sanno Hospital","ror":"https://ror.org/042vs2406","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405256373"]},{"id":"https://openalex.org/I79072001","display_name":"International University of Health and Welfare","ror":"https://ror.org/053d3tv41","country_code":"JP","type":"education","lineage":["https://openalex.org/I79072001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichiro Uchiyama","raw_affiliation_strings":["International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan;","institution_ids":["https://openalex.org/I4210162813","https://openalex.org/I4405256373","https://openalex.org/I79072001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055983723","display_name":"Takeshi Yamashita","orcid":"https://orcid.org/0000-0002-2544-8464","observed_orcids":["https://orcid.org/0000-0002-2544-8464"]},"institutions":[{"id":"https://openalex.org/I3019692003","display_name":"Cardiovascular Institute Hospital","ror":"https://ror.org/032qqvq76","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3019692003"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Yamashita","raw_affiliation_strings":["Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan;","institution_ids":["https://openalex.org/I3019692003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015689408","display_name":"Masahiro Yasaka","orcid":"https://orcid.org/0000-0002-1163-8355","observed_orcids":["https://orcid.org/0000-0002-1163-8355"]},"institutions":[{"id":"https://openalex.org/I3018397740","display_name":"National Kyushu Medical Center","ror":"https://ror.org/022296476","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3018397740","https://openalex.org/I4210137409"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Yasaka","raw_affiliation_strings":["Department of Cerebrovascular Medicine and Neurology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cerebrovascular Medicine and Neurology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan;","institution_ids":["https://openalex.org/I3018397740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050535853","display_name":"Emi Watanabe-Fujinuma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162433","display_name":"Bayer (Japan)","ror":"https://ror.org/05arv2073","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210162433","https://openalex.org/I67348948"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Emi Watanabe-Fujinuma","raw_affiliation_strings":["Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan;","institution_ids":["https://openalex.org/I4210162433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070340974","display_name":"Benjamin F. Banderas","orcid":"https://orcid.org/0000-0003-2845-2634","observed_orcids":["https://orcid.org/0000-0003-2845-2634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin F. Banderas","raw_affiliation_strings":["Adelphi Values LLC, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values LLC, Boston, MA, USA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004935858","display_name":"Sayako Akiyama","orcid":"https://orcid.org/0000-0002-5673-7832","observed_orcids":["https://orcid.org/0000-0002-5673-7832"]},"institutions":[{"id":"https://openalex.org/I4210162433","display_name":"Bayer (Japan)","ror":"https://ror.org/05arv2073","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210162433","https://openalex.org/I67348948"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sayako Akiyama","raw_affiliation_strings":["Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan;","institution_ids":["https://openalex.org/I4210162433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063280635","display_name":"Yutaka Okayama","orcid":"https://orcid.org/0000-0001-5242-1710","observed_orcids":["https://orcid.org/0000-0001-5242-1710"]},"institutions":[{"id":"https://openalex.org/I4210162433","display_name":"Bayer (Japan)","ror":"https://ror.org/05arv2073","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210162433","https://openalex.org/I67348948"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Okayama","raw_affiliation_strings":["Pharmacogivilance, Medical Affairs, Bayer Yakuhin, Ltd., Osaka, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacogivilance, Medical Affairs, Bayer Yakuhin, Ltd., Osaka, Japan;","institution_ids":["https://openalex.org/I4210162433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102778430","display_name":"J Bri\u00e8re","orcid":"https://orcid.org/0000-0002-3925-7677","observed_orcids":["https://orcid.org/0000-0002-3925-7677"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jean-Baptiste Briere","raw_affiliation_strings":["Market Access Thrombosis/Cardio-Renal, Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Market Access Thrombosis/Cardio-Renal, Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056752451","display_name":"Gavin Dickie","orcid":"https://orcid.org/0009-0006-1322-1832","observed_orcids":["https://orcid.org/0009-0006-1322-1832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin Dickie","raw_affiliation_strings":["Adelphi Values LLC, Boston, MA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelphi Values LLC, Boston, MA, USA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032472764","display_name":"Stefan Cano","orcid":"https://orcid.org/0000-0001-9390-273X","observed_orcids":["https://orcid.org/0000-0001-9390-273X"]},"institutions":[{"id":"https://openalex.org/I4405261602","display_name":"ZRx Outcomes Research Inc (Canada)","ror":"https://ror.org/05jgzc896","country_code":"CA","type":"company","lineage":["https://openalex.org/I4405261602"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Stefan J. Cano","raw_affiliation_strings":["Modus Outcomes Ltd, Letchworth Garden City, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Modus Outcomes Ltd, Letchworth Garden City, UK","institution_ids":["https://openalex.org/I4405261602"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5032472764"],"corresponding_institution_ids":["https://openalex.org/I4405261602"],"apc_list":null,"apc_paid":null,"fwci":1.1322,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78217742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"34","issue":"12","first_page":"2157","last_page":"2164"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11722","display_name":"Patient Satisfaction in Healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/treatment-satisfaction","display_name":"treatment satisfaction","score":0.9509999752044678},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9810000061988831},{"id":"https://openalex.org/keywords/treatment-satisfaction-questionnaire-for-medication","display_name":"Treatment Satisfaction Questionnaire for Medication","score":0.9660000205039978},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.7390000224113464},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.734000027179718},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.8339999914169312}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9605318307876587},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.9303052425384521},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7918949127197266},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7196269035339355},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6943026781082153},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5455121994018555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5334133505821228},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.5299369096755981},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.4144699275493622},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39480987191200256},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.15667182207107544},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000071066","descriptor_name":"Patient Reported Outcome Measures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/03007995.2018.1507315","doi":"https://doi.org/10.1080/03007995.2018.1507315","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1507315","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:30067119","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30067119","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1965492206","https://openalex.org/W1970537697","https://openalex.org/W1971505725","https://openalex.org/W1982653307","https://openalex.org/W2013498060","https://openalex.org/W2032267975","https://openalex.org/W2035533014","https://openalex.org/W2038090320","https://openalex.org/W2070567676","https://openalex.org/W2075361812","https://openalex.org/W2083882279","https://openalex.org/W2097854437","https://openalex.org/W2115787552","https://openalex.org/W2118356163","https://openalex.org/W2124639745","https://openalex.org/W2127211051","https://openalex.org/W2144317224","https://openalex.org/W2146977059","https://openalex.org/W2147399115","https://openalex.org/W2149435665","https://openalex.org/W2155441883","https://openalex.org/W2162359299","https://openalex.org/W2253201470","https://openalex.org/W2469014440","https://openalex.org/W2499224120","https://openalex.org/W2560565409","https://openalex.org/W2777982354","https://openalex.org/W2944885898","https://openalex.org/W3004050106","https://openalex.org/W4205984049","https://openalex.org/W4229847571","https://openalex.org/W4255806967"],"related_works":["https://openalex.org/W2560565409","https://openalex.org/W2888372159","https://openalex.org/W2469014440","https://openalex.org/W2773866401","https://openalex.org/W2892119345","https://openalex.org/W2618514086","https://openalex.org/W6902651685","https://openalex.org/W2118356163","https://openalex.org/W2798047319","https://openalex.org/W2200096821"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Rivaroxaban":[1],"has":[2],"previously":[3],"been":[4],"shown":[5],"to":[6,45,99,143,188,214],"be":[7],"as":[8,12,54],"efficacious":[9],"and":[10,75,91,102,117,136,184],"safe":[11],"warfarin":[13,44,213],"for":[14,80,190,228],"the":[15,76,229],"prevention":[16,231],"of":[17,56,63,119,232],"stroke":[18],"in":[19,36,68,95,111,205],"non-valvular":[20],"atrial":[21],"fibrillation":[22],"(NVAF).":[23],"Therefore,":[24],"treatment":[25,34,201,217,223],"satisfaction":[26,35,202,218],"becomes":[27],"an":[28],"important":[29],"consideration.":[30],"Here":[31],"we":[32],"examine":[33],"Japanese":[37,206],"NVAF":[38,207],"patients":[39,208],"who":[40],"were":[41,52,85,105,121],"switched":[42],"from":[43,97,212],"rivaroxaban.":[46,215],"METHODS:":[47],"Patient-reported":[48],"outcome":[49],"(PRO)":[50],"data":[51],"collected":[53,86],"part":[55],"a":[57,64,210],"prospective,":[58],"multi-center,":[59],"post-marketing":[60],"surveillance":[61],"(PMS)":[62],"direct":[65],"oral-anticoagulant,":[66],"rivaroxaban,":[67],"Japan.":[69],"The":[70],"Anti-Clot":[71],"Treatment":[72,77],"Scale":[73],"(ACTS)":[74],"Satisfaction":[78],"Questionnaire":[79],"Medication":[81],"version":[82],"II":[83],"(TSQM-II)":[84],"at":[87,130,181],"baseline,":[88],"month":[89,92,100,103,131,137,163,169,182,185],"3,":[90],"6.":[93],"Change":[94],"scores":[96,112,127,178],"baseline":[98,144,189],"3":[101,132,164,183],"6":[104,138,170,186],"assessed.":[106,123],"Exploratory":[107],"analyses":[108],"included":[109],"change":[110],"by":[113],"patient":[114],"characteristics.":[115],"Safety":[116],"effectiveness":[118],"rivaroxaban":[120],"also":[122],"RESULTS:":[124],"ACTS":[125,151],"Burdens":[126],"significantly":[128,179],"improved":[129,180,222],"(54.6":[133],"\u00b1":[134,140,146,161,167,173],"6.3)":[135],"(54.5":[139],"6.5)":[141],"compared":[142,187],"(51.0":[145],"7.6)":[147],"(p":[148],"<":[149,196],".001).":[150,197],"Benefits":[152],"score":[153],"remained":[154],"stable":[155],"over":[156],"time":[157],"(baseline":[158],"=":[159,165,171],"10.1":[160,172],"2.8,":[162],"10.2":[166],"3.1,":[168],"3.1).":[174],"Mean":[175],"TSQM-II":[176],"sub-scale":[177],"all":[191],"four":[192],"domains":[193],"(all":[194],"p":[195],"CONCLUSIONS:":[198],"Findings":[199],"suggest":[200],"may":[203,219],"improve":[204],"after":[209],"switch":[211],"Higher":[216],"translate":[220],"into":[221],"adherence,":[224],"which":[225],"is":[226],"critical":[227],"long-term":[230],"stroke.":[233]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-08-22T00:00:00"}